심장 아밀로이드증 환자의 한의학적 치험 1례 증례보고
A Case Report of Korean Medicine Treatment for Cardiac Amyloidosis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Introduction: Cardiac amyloidosis is a rare form of cardiomyopathy caused by amyloid deposition in the myocardium. This study reported on the effects of Korean medicine treatment on a patient with cardiac amyloidosis. Case Summary: A 60-year-old male patient visited a Korean medical clinic with dyspnea, general weakness, multiple pains in the lower back, right hip joint, and both knee joints, and tingling sensations in both the upper and lower limbs. The patient was treated with acupuncture using a combination of multiple acupoints, cupping, and Western medications. After 84 outpatient treatments, most subjective symptoms, including multiple pains, tingling sensations, general weakness, and abdominal discomfort, were relieved. The numeric rating scale (NRS) scores for low back pain and right hip joint pain decreased from 8 (Day 1) to 0 (Day 124). Conclusion: This report suggests that Korean medical treatment could be a viable option for symptom management in patients with cardiac amyloidosis.
Abstract
Introduction: Cardiac amyloidosis is a rare form of cardiomyopathy caused by amyloid deposition in the myocardium. This study reported on the effects of Korean medicine treatment on a patient with cardiac amyloidosis. Case Summary: A 60-year-old male patient visited a Korean medical clinic with dyspnea, general weakness, multiple pains in the lower back, right hip joint, and both knee joints, and tingling sensations in both the upper and lower limbs. The patient was treated with acupuncture using a combination of multiple acupoints, cupping, and Western medications. After 84 outpatient treatments, most subjective symptoms, including multiple pains, tingling sensations, general weakness, and abdominal discomfort, were relieved. The numeric rating scale (NRS) scores for low back pain and right hip joint pain decreased from 8 (Day 1) to 0 (Day 124). Conclusion: This report suggests that Korean medical treatment could be a viable option for symptom management in patients with cardiac amyloidosis.
참고문헌 (17)
- Grogan M, "Natural history of wild-type transthyretin cardiac amyloidosis andrisk stratification using a novel staging system", J Am Coll Cardiol, 68(10), pp.1014~1020 (2016)
- Lane T, "Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis", Circulation, 140(1), pp.16~26 (2019)
- Mohammed SF, "Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction", JACC Heart Fail, 2(2), pp.113~122 (2014)
- Castano A, "Multicenter study of planar technetium 99m pyrophosphate cardiac imaging : predicting survival for patients with ATTR cardiac amyloidosis", JAMA Cardiol, 1(8), pp.880~889 (2016)
- Maurer MS, "Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy", N Engl J Med, 379(11), pp.1007~1016 (2018)
- Berk JL, "Repurposing diflunisal for familial amyloid polyneuropathy : a randomized clinical trial", JAMA, 310(24), pp.2658~2667 (2013)
- Adams D, "Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis", N Engl J Med, 379(1), pp.11~21 (2018)
- Benson MD, "Inotersen treatment for patients with hereditary transthyretin amyloidosis", N Engl J Med, 379(1), pp.22~31 (2018)
- Jun CY, "The Literature Study of True Heartache", The Journal of Internal Korean Medicine, 11(1), pp.121~126 (1990)
- Lee H, "Acupuncture for heart failure : A systematic review of clinical studies", Int J Cardiol, 222, pp.321~331 (2016)
- Park S, "Network Analysis Using the Established Database(K-herb Network)on Herbal Medicines Used in Clinical Research on Heart Failure", The Journal of Internal Korean Medicine, 44(3), pp.313~353 (2023)
- Kim M, "A Case Report of Peripheral Neuropathy after Induction Chemotherapy before Autologous Peripheral Blood Stem Cell Transplantation in a Patient with Multiple Myeloma with Amyloidosis Treated with Complex Korean Medicine Treatment", The Journal of Internal Korean Medicine, 44(5), pp.1092~1100 (2023)
- Ernst E, "Life-threatening adverse reactions after acupuncture? A systematic review", Pain, 71(2), pp.123~126 (1997)
- Shin SC, "Amyloid neuropathies", Mt Sinai J Med, 79(6), pp.733~748 (2012)
- Huber P, "A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy", Amyloid, 26(4), pp.203~209 (2019)
- Elliott P, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy", Circ Heart Fail, 15(1), pp.e008193~ (2022)
- Lamb YN, "Tafamidis : A Review in Transthyretin Amyloidosis with Polyneuropathy", Drugs, 79(8), pp.863~874 (2019)